IL-33 EXPRESSION CONTROL AGENT, ADJUVANT, BIOMARKER FOR ALLERGY INFLAMMATION DETECTION, METHOD FOR ACQUIRING DATA FOR DIAGNOSING ALLERGY INFLAMMATION, METHOD FOR IDENTIFYING ALLERGIC DISEASE PATIENT, SCREENING METHOD FOR IL-33 EXPRESSION INDUCER, METHOD OF EVALUATING THE EFFICACY AND SIDE EFFECT OF TEST DRUG, AND THERAPEUTIC AGENT

摘要

PROBLEM TO BE SOLVED: To provide an agent that controls IL-33 expression to be positive or negative.;SOLUTION: An agent contains an active ingredient selected from Putative hydrolase RBBP9, PGE1, PGE2, EP2, EP4, EP2 agonist, EP4 agonist, COX-2, COX-2 activator, Centrosomal protein of 170kDa, Cathepsin S, NADH-cytochrome b5 reductase 3, Tight junction protein ZO-2, Guanylate kinase, Myotubularin-related protein 10, Eukaryotic translation initiation factor 4H and the like.;SELECTED DRAWING: None;COPYRIGHT: (C)2018,JPO&INPIT